HISUN(SH:600267) Zhi Tong Cai Jing·2025-11-06 08:46Core Viewpoint - Haizheng Pharmaceutical (600267.SH) has received approval from the Ministry of Agriculture and Rural Affairs of the People's Republic of China for two veterinary drug products, which will enhance its product line and market competitiveness in the veterinary medicine sector [1] Group 1 - The company’s subsidiary, Zhejiang Haizheng Animal Health Products Co., Ltd., has been granted approval for the compound streptomycin ointment and torquatozole suspension veterinary drug products [1] - The approval will enrich the company's veterinary drug product line and structure, supporting its strategic layout in the veterinary medicine sector [1] - This development is expected to improve the company's market competitiveness in the veterinary drug market [1]